- Big Bank Phobia: Not Too Big to Fail
- Expect Your Health Care in Retirement to Hit $200,000
- Why Car Prices Vary From City To City
- Biotech Stock Mailbag: Vical, Sangamo, Spectrum Pharma
- 5 Worst Home Renovation Projects
Ireland Welcomes Watson Pharmaceuticals, an American Success
Another entrepreneurial U.S. startup bites the dust... sort of.
05/20/13 - 02:27 PM EDT
Video
Biotech's Next Big Thing -- ASCO II
TheStreet senior columnist Adam Feuerstein discusses the winners and losers from the research abstracts ahead of the ASCO cancer conference.
05/16/13 - 02:09 PM EDT
The 5 Dumbest Things on Wall Street This Week: May 17
Dan Loeb gets soft, Bloomberg and traders are 'Spy vs. Spy,' and Wal-Mart torpedos a cooperative reform effort by choosing its own, awkward path.
05/17/13 - 07:00 AM EDT
10 ASCO '13 Abstracts You Can Read Right Now
Get a head start on searching through ASCO abstracts with these 10 summaries.
05/15/13 - 06:00 PM EDT
Aveo Screwed Up but Its Kidney Cancer Drug Is Real
At some point, investors will give Aveo credit for tivozanib, says David Sobek.
05/15/13 - 09:24 AM EDT
Synta Is Run-Up to ASCO Lung Cancer Data
The market overreacted to the resignation of Synta's R&D chief.
05/14/13 - 10:16 AM EDT
Cullen/Frost Has Earned Its Premium, and More
The stock has the highest forward P/E among components of the KBW Bank Index, justified by strong long-term earnings and growth prospects.
05/14/13 - 10:23 AM EDT
Video
Quintiles IPO Trades Higher
Quintiles Transnational prices its IPo at the high end of the range and moves higher in trading. CEO Tom Pike sees more growth ahead.
05/13/13 - 10:47 AM EDT
The Deal: Bain, TPG Get Windfall With Quintiles IPO
- Tickers in this article:
- Q
Quintiles raises $947 million for investors including Bain and TPG Group as the research services company goes public.
05/10/13 - 11:51 AM EDT
SEC Is Investigating Spectrum Pharma
- Tickers in this article:
- SPPI
Regulators have issued a subpoena to Spectrum for information related to the steep cut in Fusilev sales in 2013.
05/13/13 - 07:19 AM EDT
Video
Biotech's Next Big Thing: ASCO
TheStreet Sr. Columnst Adam Feuerstein previews the research abstracts presented next week in advance of June's ASCO cancer event.
05/09/13 - 09:39 AM EDT
Biotech Stock Mailbag: Synta, Zogenix, Sarepta, Amarin
Biotech columnist Adam Feuerstein answers readers' questions about health-care companies.
05/10/13 - 07:00 AM EDT
